Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 209 entries
Sorted by: Best Match Show Resources per page
Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer.

Annals of surgical oncology

Loverro M, Ergasti R, Conte C, Gallitelli V, Nachira D, Scaglione G, Fagotti A, Scambia G, Gallotta V.
PMID: 35000090
Ann Surg Oncol. 2022 Jan 08; doi: 10.1245/s10434-021-11267-5. Epub 2022 Jan 08.

No abstract available.

Cite
Loverro M, Ergasti R, Conte C, et al. Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer. Ann Surg Oncol. 2022;doi: 10.1245/s10434-021-11267-5.
Loverro, M., Ergasti, R., Conte, C., Gallitelli, V., Nachira, D., Scaglione, G., Fagotti, A., Scambia, G., & Gallotta, V. (2022). Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer. Annals of surgical oncology, . https://doi.org/10.1245/s10434-021-11267-5
Loverro, M, et al. "Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer." Annals of surgical oncology vol. (2022). doi: https://doi.org/10.1245/s10434-021-11267-5
Loverro M, Ergasti R, Conte C, Gallitelli V, Nachira D, Scaglione G, Fagotti A, Scambia G, Gallotta V. Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer. Ann Surg Oncol. 2022 Jan 08; doi: 10.1245/s10434-021-11267-5. Epub 2022 Jan 08. PMID: 35000090.
Copy Download .nbib Format: NLM
Current Standards for and Clinical Impact of Emergency Radiology in Major Trauma.

International journal of environmental research and public health

Iacobellis F, Abu-Omar A, Crivelli P, Galluzzo M, Danzi R, Trinci M, Dell'Aversano Orabona G, Conti M, Romano L, Scaglione M.
PMID: 35010799
Int J Environ Res Public Health. 2022 Jan 04;19(1). doi: 10.3390/ijerph19010539.

In industrialized countries, high energy trauma represents the leading cause of death and disability among people under 35 years of age. The two leading causes of mortality are neurological injuries and bleeding. Clinical evaluation is often unreliable in determining...

Cite
Iacobellis F, Abu-Omar A, Crivelli P, et al. Current Standards for and Clinical Impact of Emergency Radiology in Major Trauma. Int J Environ Res Public Health. 2022;19(1)doi: 10.3390/ijerph19010539.
Iacobellis, F., Abu-Omar, A., Crivelli, P., Galluzzo, M., Danzi, R., Trinci, M., Dell'Aversano Orabona, G., Conti, M., Romano, L., & Scaglione, M. (2022). Current Standards for and Clinical Impact of Emergency Radiology in Major Trauma. International journal of environmental research and public health, 19(1), . https://doi.org/10.3390/ijerph19010539
Iacobellis, Francesca, et al. "Current Standards for and Clinical Impact of Emergency Radiology in Major Trauma." International journal of environmental research and public health vol. 19,1 (2022). doi: https://doi.org/10.3390/ijerph19010539
Iacobellis F, Abu-Omar A, Crivelli P, Galluzzo M, Danzi R, Trinci M, Dell'Aversano Orabona G, Conti M, Romano L, Scaglione M. Current Standards for and Clinical Impact of Emergency Radiology in Major Trauma. Int J Environ Res Public Health. 2022 Jan 04;19(1). doi: 10.3390/ijerph19010539. PMID: 35010799.
Copy Download .nbib Format: NLM
PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis.

Cells

Mercurio L, Morelli M, Scarponi C, Scaglione GL, Pallotta S, Albanesi C, Madonna S.
PMID: 34685616
Cells. 2021 Oct 02;10(10). doi: 10.3390/cells10102636.

The phosphatidylinositol 3-kinase (PI3K)-dependent signaling pathway is aberrantly activated in psoriatic lesions and contributes to disease pathogenesis. Among PI3Ks enzymes, PI3Kα, β, and δ isoforms are known to bind the p85 regulatory subunit and mediate activation of AKT and...

Cite
Mercurio L, Morelli M, Scarponi C, et al. PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis. Cells. 2021;10(10)doi: 10.3390/cells10102636.
Mercurio, L., Morelli, M., Scarponi, C., Scaglione, G. L., Pallotta, S., Albanesi, C., & Madonna, S. (2021). PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis. Cells, 10(10), . https://doi.org/10.3390/cells10102636
Mercurio, Laura, et al. "PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis." Cells vol. 10,10 (2021). doi: https://doi.org/10.3390/cells10102636
Mercurio L, Morelli M, Scarponi C, Scaglione GL, Pallotta S, Albanesi C, Madonna S. PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis. Cells. 2021 Oct 02;10(10). doi: 10.3390/cells10102636. PMID: 34685616; PMCID: PMC8534452.
Copy Download .nbib Format: NLM
Impact of ablation index settings on pulmonary vein reconnection.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

Lepillier A, Strisciuglio T, De Ruvo E, Scaglione M, Anselmino M, Sebag FA, Pecora D, Gallagher MM, Rillo M, Viola G, Pisanò E, Abbey S, Lamberti F, Pani A, Zucchelli G, Sgarito G, De Simone A, Bertaglia E, Solimene F, Stabile G.
PMID: 33570717
J Interv Card Electrophysiol. 2021 Feb 11; doi: 10.1007/s10840-021-00944-w. Epub 2021 Feb 11.

PURPOSE: Ablation index (AI) is a radiofrequency lesion quality marker. The AI value that allows effective and safe pulmonary vein isolation (PVI) is still debated. We evaluated the incidence of acute and late PV reconnection (PVR) with different AI...

Cite
Lepillier A, Strisciuglio T, De Ruvo E, et al. Impact of ablation index settings on pulmonary vein reconnection. J Interv Card Electrophysiol. 2021;doi: 10.1007/s10840-021-00944-w.
Lepillier, A., Strisciuglio, T., De Ruvo, E., Scaglione, M., Anselmino, M., Sebag, F. A., Pecora, D., Gallagher, M. M., Rillo, M., Viola, G., Pisanò, E., Abbey, S., Lamberti, F., Pani, A., Zucchelli, G., Sgarito, G., De Simone, A., Bertaglia, E., Solimene, F., & Stabile, G. (2021). Impact of ablation index settings on pulmonary vein reconnection. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, . https://doi.org/10.1007/s10840-021-00944-w
Lepillier, A, et al. "Impact of ablation index settings on pulmonary vein reconnection." Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing vol. (2021). doi: https://doi.org/10.1007/s10840-021-00944-w
Lepillier A, Strisciuglio T, De Ruvo E, Scaglione M, Anselmino M, Sebag FA, Pecora D, Gallagher MM, Rillo M, Viola G, Pisanò E, Abbey S, Lamberti F, Pani A, Zucchelli G, Sgarito G, De Simone A, Bertaglia E, Solimene F, Stabile G. Impact of ablation index settings on pulmonary vein reconnection. J Interv Card Electrophysiol. 2021 Feb 11; doi: 10.1007/s10840-021-00944-w. Epub 2021 Feb 11. PMID: 33570717.
Copy Download .nbib Format: NLM
SARS-COV-2 SCREENING IN ALLOGENEIC HEMATOPOIETIC STEM CELL DONORS: IMPLICATIONS FOR THE EVALUATION PROCESS AND ELIGIBILITY.

Hematology, transfusion and cell therapy

Crocchiolo R, Alfarano F, Volpato E, Pugliano M, Cuppari I, Mazza AM, Bellio L, Fanti D, Vismara C, Scaglione F, Sacchi N, Pollichieni S, Mele L, Diral E, Grillo G, Rossini S.
PMID: 34901751
Hematol Transfus Cell Ther. 2021 Dec 07; doi: 10.1016/j.htct.2021.09.017. Epub 2021 Dec 07.

INTRODUCTION: Soon after the onset of the SARS-CoV-2 pandemic, viral screening by nasopharyngeal swab became mandatory for allogeneic hematopoietic stem cell (HSC) donor eligibility.METHODS: We described our monocenter experience with allogeneic HSC donors from February 1 to the October...

Cite
Crocchiolo R, Alfarano F, Volpato E, et al. SARS-COV-2 SCREENING IN ALLOGENEIC HEMATOPOIETIC STEM CELL DONORS: IMPLICATIONS FOR THE EVALUATION PROCESS AND ELIGIBILITY. Hematol Transfus Cell Ther. 2021;doi: 10.1016/j.htct.2021.09.017.
Crocchiolo, R., Alfarano, F., Volpato, E., Pugliano, M., Cuppari, I., Mazza, A. M., Bellio, L., Fanti, D., Vismara, C., Scaglione, F., Sacchi, N., Pollichieni, S., Mele, L., Diral, E., Grillo, G., & Rossini, S. (2021). SARS-COV-2 SCREENING IN ALLOGENEIC HEMATOPOIETIC STEM CELL DONORS: IMPLICATIONS FOR THE EVALUATION PROCESS AND ELIGIBILITY. Hematology, transfusion and cell therapy, . https://doi.org/10.1016/j.htct.2021.09.017
Crocchiolo, Roberto, et al. "SARS-COV-2 SCREENING IN ALLOGENEIC HEMATOPOIETIC STEM CELL DONORS: IMPLICATIONS FOR THE EVALUATION PROCESS AND ELIGIBILITY." Hematology, transfusion and cell therapy vol. (2021). doi: https://doi.org/10.1016/j.htct.2021.09.017
Crocchiolo R, Alfarano F, Volpato E, Pugliano M, Cuppari I, Mazza AM, Bellio L, Fanti D, Vismara C, Scaglione F, Sacchi N, Pollichieni S, Mele L, Diral E, Grillo G, Rossini S. SARS-COV-2 SCREENING IN ALLOGENEIC HEMATOPOIETIC STEM CELL DONORS: IMPLICATIONS FOR THE EVALUATION PROCESS AND ELIGIBILITY. Hematol Transfus Cell Ther. 2021 Dec 07; doi: 10.1016/j.htct.2021.09.017. Epub 2021 Dec 07. PMID: 34901751; PMCID: PMC8648663.
Copy Download .nbib Format: NLM
Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis.

Archives of gynecology and obstetrics

Inzani F, Santoro A, Travaglino A, D'Alessandris N, Raffone A, Straccia P, Angelico G, Arciuolo D, Scaglione G, Valente M, Tralongo P, Gallotta V, Zannoni GF.
PMID: 34799743
Arch Gynecol Obstet. 2021 Nov 19; doi: 10.1007/s00404-021-06305-2. Epub 2021 Nov 19.

BACKGROUND: Ovarian adult granulosa cell tumours are low-grade malignant sex cord-stromal neoplasm with a low recurrence rate. Prognostic factors for recurrence include tumor stage, tumor rupture in Stage I neoplasms and the presence of residual tumors after surgery. However,...

Cite
Inzani F, Santoro A, Travaglino A, et al. Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;doi: 10.1007/s00404-021-06305-2.
Inzani, F., Santoro, A., Travaglino, A., D'Alessandris, N., Raffone, A., Straccia, P., Angelico, G., Arciuolo, D., Scaglione, G., Valente, M., Tralongo, P., Gallotta, V., & Zannoni, G. F. (2021). Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis. Archives of gynecology and obstetrics, . https://doi.org/10.1007/s00404-021-06305-2
Inzani, Frediano, et al. "Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis." Archives of gynecology and obstetrics vol. (2021). doi: https://doi.org/10.1007/s00404-021-06305-2
Inzani F, Santoro A, Travaglino A, D'Alessandris N, Raffone A, Straccia P, Angelico G, Arciuolo D, Scaglione G, Valente M, Tralongo P, Gallotta V, Zannoni GF. Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021 Nov 19; doi: 10.1007/s00404-021-06305-2. Epub 2021 Nov 19. PMID: 34799743.
Copy Download .nbib Format: NLM
Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management.

ESMO open

Vallerio P, Orenti A, Tosi F, Maistrello M, Palazzini M, Cingarlini S, Colombo P, Bertuzzi M, Spina F, Amatu A, Lombardo R, Prata I, Scaglione F, Vighi GD, Severgnini B, Siena S, Giannattasio C, Boracchi P, Sartore-Bianchi A.
PMID: 34920290
ESMO Open. 2021 Dec 14;7(1):100338. doi: 10.1016/j.esmoop.2021.100338. Epub 2021 Dec 14.

BACKGROUND: Vascular endothelial growth factor receptor (VEGFR)-targeted tyrosine kinase inhibitors (TKIs) are widely used in cancer treatment and burdened by cardiovascular toxicity. The majority of data come from clinical trials, thus in selected populations. The aim of our study...

Cite
Vallerio P, Orenti A, Tosi F, et al. Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management. ESMO Open. 2021;7(1):100338doi: 10.1016/j.esmoop.2021.100338.
Vallerio, P., Orenti, A., Tosi, F., Maistrello, M., Palazzini, M., Cingarlini, S., Colombo, P., Bertuzzi, M., Spina, F., Amatu, A., Lombardo, R., Prata, I., Scaglione, F., Vighi, G. D., Severgnini, B., Siena, S., Giannattasio, C., Boracchi, P., & Sartore-Bianchi, A. (2021). Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management. ESMO open, 7(1), 100338. https://doi.org/10.1016/j.esmoop.2021.100338
Vallerio, P, et al. "Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management." ESMO open vol. 7,1 (2021): 100338. doi: https://doi.org/10.1016/j.esmoop.2021.100338
Vallerio P, Orenti A, Tosi F, Maistrello M, Palazzini M, Cingarlini S, Colombo P, Bertuzzi M, Spina F, Amatu A, Lombardo R, Prata I, Scaglione F, Vighi GD, Severgnini B, Siena S, Giannattasio C, Boracchi P, Sartore-Bianchi A. Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management. ESMO Open. 2021 Dec 14;7(1):100338. doi: 10.1016/j.esmoop.2021.100338. Epub 2021 Dec 14. PMID: 34920290; PMCID: PMC8685997.
Copy Download .nbib Format: NLM
Combining Optogenetic Stimulation and Motor Training Improves Functional Recovery and Perilesional Cortical Activity.

Neurorehabilitation and neural repair

Conti E, Scaglione A, de Vito G, Calugi F, Pasquini M, Pizzorusso T, Micera S, Allegra Mascaro AL, Pavone FS.
PMID: 34761714
Neurorehabil Neural Repair. 2021 Nov 11;15459683211056656. doi: 10.1177/15459683211056656. Epub 2021 Nov 11.

No abstract available.

Cite
Conti E, Scaglione A, de Vito G, et al. Combining Optogenetic Stimulation and Motor Training Improves Functional Recovery and Perilesional Cortical Activity. Neurorehabil Neural Repair. 2021;15459683211056656doi: 10.1177/15459683211056656.
Conti, E., Scaglione, A., de Vito, G., Calugi, F., Pasquini, M., Pizzorusso, T., Micera, S., Allegra Mascaro, A. L., & Pavone, F. S. (2021). Combining Optogenetic Stimulation and Motor Training Improves Functional Recovery and Perilesional Cortical Activity. Neurorehabilitation and neural repair, 15459683211056656. https://doi.org/10.1177/15459683211056656
Conti, Emilia, et al. "Combining Optogenetic Stimulation and Motor Training Improves Functional Recovery and Perilesional Cortical Activity." Neurorehabilitation and neural repair vol. (2021): 15459683211056656. doi: https://doi.org/10.1177/15459683211056656
Conti E, Scaglione A, de Vito G, Calugi F, Pasquini M, Pizzorusso T, Micera S, Allegra Mascaro AL, Pavone FS. Combining Optogenetic Stimulation and Motor Training Improves Functional Recovery and Perilesional Cortical Activity. Neurorehabil Neural Repair. 2021 Nov 11;15459683211056656. doi: 10.1177/15459683211056656. Epub 2021 Nov 11. PMID: 34761714.
Copy Download .nbib Format: NLM
A novel smaller β-defensin-derived peptide is active against multidrug-resistant bacterial strains.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Colicchio R, Nigro E, Colavita I, Pagliuca C, Di Maro S, Tomassi S, Scaglione E, Carbone F, Carriero MV, Matarese G, Daniele A, Cosconati S, Pessi A, Salvatore F, Salvatore P.
PMID: 34818435
FASEB J. 2021 Dec;35(12):e22026. doi: 10.1096/fj.202002330RR.

Antibiotic resistance is becoming a severe obstacle in the fight against acute and chronic infectious diseases that accompany most degenerative illnesses from neoplasia to osteo-arthritis and obesity. Currently, the race is on to identify pharmaceutical molecules or combinations of...

Cite
Colicchio R, Nigro E, Colavita I, et al. A novel smaller β-defensin-derived peptide is active against multidrug-resistant bacterial strains. FASEB J. 2021;35(12):e22026doi: 10.1096/fj.202002330RR.
Colicchio, R., Nigro, E., Colavita, I., Pagliuca, C., Di Maro, S., Tomassi, S., Scaglione, E., Carbone, F., Carriero, M. V., Matarese, G., Daniele, A., Cosconati, S., Pessi, A., Salvatore, F., & Salvatore, P. (2021). A novel smaller β-defensin-derived peptide is active against multidrug-resistant bacterial strains. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35(12), e22026. https://doi.org/10.1096/fj.202002330RR
Colicchio, Roberta, et al. "A novel smaller β-defensin-derived peptide is active against multidrug-resistant bacterial strains." FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 35,12 (2021): e22026. doi: https://doi.org/10.1096/fj.202002330RR
Colicchio R, Nigro E, Colavita I, Pagliuca C, Di Maro S, Tomassi S, Scaglione E, Carbone F, Carriero MV, Matarese G, Daniele A, Cosconati S, Pessi A, Salvatore F, Salvatore P. A novel smaller β-defensin-derived peptide is active against multidrug-resistant bacterial strains. FASEB J. 2021 Dec;35(12):e22026. doi: 10.1096/fj.202002330RR. PMID: 34818435.
Copy Download .nbib Format: NLM
Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis.

Gynecologic oncology

Travaglino A, Raffone A, Santoro A, Raimondo D, Angelico G, Valente M, Arciuolo D, Scaglione G, D'alessandris N, Casadio P, Inzani F, Mollo A, Seracchioli R, Zannoni GF.
PMID: 34266691
Gynecol Oncol. 2021 Sep;162(3):804-808. doi: 10.1016/j.ygyno.2021.07.007. Epub 2021 Jul 12.

INTRODUCTION: In the ESGO/ESTRO/ESP guidelines for endometrial carcinoma management, the risk category of clear cell carcinoma (CCC) is not well defined. In fact, while p53-abnormal (p53abn) CCC are known to be aggressive, the prognosis of mismatch repair-deficient (MMRd) and...

Cite
Travaglino A, Raffone A, Santoro A, et al. Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis. Gynecol Oncol. 2021;162(3):804-808doi: 10.1016/j.ygyno.2021.07.007.
Travaglino, A., Raffone, A., Santoro, A., Raimondo, D., Angelico, G., Valente, M., Arciuolo, D., Scaglione, G., D'alessandris, N., Casadio, P., Inzani, F., Mollo, A., Seracchioli, R., & Zannoni, G. F. (2021). Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis. Gynecologic oncology, 162(3), 804-808. https://doi.org/10.1016/j.ygyno.2021.07.007
Travaglino, Antonio, et al. "Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis." Gynecologic oncology vol. 162,3 (2021): 804-808. doi: https://doi.org/10.1016/j.ygyno.2021.07.007
Travaglino A, Raffone A, Santoro A, Raimondo D, Angelico G, Valente M, Arciuolo D, Scaglione G, D'alessandris N, Casadio P, Inzani F, Mollo A, Seracchioli R, Zannoni GF. Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis. Gynecol Oncol. 2021 Sep;162(3):804-808. doi: 10.1016/j.ygyno.2021.07.007. Epub 2021 Jul 12. PMID: 34266691.
Copy Download .nbib Format: NLM
Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity.

bioRxiv : the preprint server for biology

Scaglione A, Opp S, Hurtado A, Lin Z, Pampeno C, Noval MG, Thannickal SA, Stapleford KA, Meruelo D.
PMID: 34075383
bioRxiv. 2021 Jun 02; doi: 10.1101/2021.05.28.446009.

The COVID-19 pandemic caused by the coronavirus SARS-CoV-2 is a major global public threat. Currently, a worldwide effort has been mounted to generate billions of effective SARS-CoV-2 vaccine doses to immunize the world's population at record speeds. However, there...

Cite
Scaglione A, Opp S, Hurtado A, et al. Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity. bioRxiv. 2021;doi: 10.1101/2021.05.28.446009.
Scaglione, A., Opp, S., Hurtado, A., Lin, Z., Pampeno, C., Noval, M. G., Thannickal, S. A., Stapleford, K. A., & Meruelo, D. (2021). Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.05.28.446009
Scaglione, Antonella, et al. "Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.05.28.446009
Scaglione A, Opp S, Hurtado A, Lin Z, Pampeno C, Noval MG, Thannickal SA, Stapleford KA, Meruelo D. Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity. bioRxiv. 2021 Jun 02; doi: 10.1101/2021.05.28.446009. PMID: 34075383; PMCID: PMC8168399.
Copy Download .nbib Format: NLM
Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management.

ESMO open

Vallerio P, Orenti A, Tosi F, Maistrello M, Palazzini M, Cingarlini S, Colombo P, Bertuzzi M, Spina F, Amatu A, Lombardo R, Prata I, Scaglione F, Vighi GD, Severgnini B, Siena S, Giannattasio C, Boracchi P, Sartore-Bianchi A.
PMID: 34920290
ESMO Open. 2021 Dec 14;7(1):100338. doi: 10.1016/j.esmoop.2021.100338. Epub 2021 Dec 14.

BACKGROUND: Vascular endothelial growth factor receptor (VEGFR)-targeted tyrosine kinase inhibitors (TKIs) are widely used in cancer treatment and burdened by cardiovascular toxicity. The majority of data come from clinical trials, thus in selected populations. The aim of our study...

Cite
Vallerio P, Orenti A, Tosi F, et al. Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management. ESMO Open. 2021;7(1):100338doi: 10.1016/j.esmoop.2021.100338.
Vallerio, P., Orenti, A., Tosi, F., Maistrello, M., Palazzini, M., Cingarlini, S., Colombo, P., Bertuzzi, M., Spina, F., Amatu, A., Lombardo, R., Prata, I., Scaglione, F., Vighi, G. D., Severgnini, B., Siena, S., Giannattasio, C., Boracchi, P., & Sartore-Bianchi, A. (2021). Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management. ESMO open, 7(1), 100338. https://doi.org/10.1016/j.esmoop.2021.100338
Vallerio, P, et al. "Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management." ESMO open vol. 7,1 (2021): 100338. doi: https://doi.org/10.1016/j.esmoop.2021.100338
Vallerio P, Orenti A, Tosi F, Maistrello M, Palazzini M, Cingarlini S, Colombo P, Bertuzzi M, Spina F, Amatu A, Lombardo R, Prata I, Scaglione F, Vighi GD, Severgnini B, Siena S, Giannattasio C, Boracchi P, Sartore-Bianchi A. Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management. ESMO Open. 2021 Dec 14;7(1):100338. doi: 10.1016/j.esmoop.2021.100338. Epub 2021 Dec 14. PMID: 34920290.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 209 entries